Improper access control in Oracle Life Sciences Empirica Signal
Key facts
- Attack vector
- Network
- Privileges required
- Low
- User interaction
- None
- Attack complexity
- Low
- Impact type
- Security bypass
- Confidentiality · integrity · availability
- Low · High · None
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-284.
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2026-21997
- 2026-10-03 Alias added: GHSA-fjgq-vg76-2mmp
References
Advisory 1
Sources
- CVE-2026-21997 · CVE Program
- CVE-2026-21997 · NVD
- FIRST EPSS
- GHSA-fjgq-vg76-2mmp · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences